Clinical-stage biopharmaceutical company Azitra has announced promising ex vivo results for its ATR-COSF program — a cosmetic ingredient formulated from a supernatant derived from an engineered strain of S. epidermidis that secretes a functional unit of the human filaggrin protein, a key component for skin health.
In a multiple-dose study using fresh human skin explants stimulated with TH2 cytokines to reduce native filaggrin levels, the company demonstrated that a 2% lyophilized supernatant in a hydrogel formulation achieved increased penetration and distribution of the recombinant protein through the stratum corneum and into the stratum granulosum with repeated applications. A separate ex vivo study assessed the effect of varying concentrations of the lyophilized supernatant in a hydrogel on human skin elasticity, revealing a dose-dependent enhancement where a 0.28% concentration restored abdominoplasty skin elasticity to levels historically observed in healthy skin, and a 0.3% formulation produced approximately twice the elasticity of a placebo-treated sample.
Elasticity-Promoting Cosmetic Ingredients
Azitra Unveils Positive Results for the ATR-COSF Program
Trend Themes
-
Bioengineered Skin Actives — Engineered microbiome-derived ingredients are creating new pathways for cosmetic formulas that mimic or deliver human skin proteins with targeted functional benefits.
-
Elasticity-restoring Formulations — Dose-responsive cosmetic compounds that visibly improve skin elasticity highlight potential for performance-led anti-aging products positioned beyond traditional moisturization claims.
-
Ex Vivo Beauty Testing — Human skin explant studies are strengthening cosmetic ingredient validation by offering more biologically relevant evidence before consumer-facing product development.
Industry Implications
-
Cosmetics — Advanced active ingredients with clinically supported skin-barrier and elasticity benefits are reshaping premium skincare competition and product differentiation.
-
Biopharmaceuticals — Therapeutic biotech platforms are expanding into cosmetic applications as engineered proteins and microbial systems generate commercially versatile skin-health solutions.
-
Dermatology — Barrier-focused innovations inspired by filaggrin biology are blurring the line between dermatological care and cosmetic enhancement for sensitive and aging skin.